News | January 27, 2022
Minimizing API losses critical to responsible pharma manufacturing
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
The covid health center will be managed and administered by the district administration of Ballari
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Six months after receipt of the second Covaxin dose, participants received booster dose of the same. The trial demonstrated long-term safety with no serious events
Biogen paid Ionis a US $ 60 million one-time upfront payment
The first pilot study from India analyzing Covaxin-Covishield mixed doses
Subscribe To Our Newsletter & Stay Updated
